Boston Private Bank & Trust’s Celgene Corp CELG Stock Holding History

Boston Private Bank & Trust’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$18.4M	Buy	159,449 +43	+0%	+$5.14K	0.85%	35
2014 Q4	$17.8M	Buy	159,406 +2,221	+1%	+$234K	0.83%	35
2014 Q3	$14.9M	Buy	157,185 +6,735	+4%	+$608K	0.73%	42
2014 Q2	$12.9M	Buy	150,450 +19,040	+14%	+$1.45M	0.63%	54
2014 Q1	$9.17M	Buy	131,410 +5,306	+4%	+$420K	0.46%	71
2013 Q4	$10.7M	Buy	126,104 +934	+0.7%	+$73.9K	0.53%	64
2013 Q3	$9.65M	Buy	125,170 +35,724	+40%	+$2.5M	0.54%	64
2013 Q2	$5.23M	Buy	+89,446	New	+$5.38M	0.3%	100

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Boston Private Bank & Trust's CELG Position: Q1 2015 in Review

Boston Private Bank & Trust increased its Celgene Corp (CELG) stake by 0.03% in Q1 2015, buying an estimated $5.14K and bringing the position to 159,449 shares worth $18.4M. The position accounts for 0.85% of the portfolio, ranked #35.

Boston Private Bank & Trust first reported a position in CELG in Q2 2013 and has held it in 8 quarters since. 1,193 funds tracked by Wall St. Rank hold CELG as of Q1 2015.

Boston Private Bank & Trust held 159,449 shares of Celgene Corp worth $18.4M as of Q1 2015.
Boston Private Bank & Trust bought 43 Celgene Corp shares in Q1 2015, an estimated $5.14K.
Celgene Corp made up 0.85% of Boston Private Bank & Trust's portfolio in Q1 2015, its #35 holding.
Boston Private Bank & Trust first reported a position in Celgene Corp in Q2 2013 and has held it in 8 quarters since.
1,193 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.